tiprankstipranks
Trending News
More News >
GenSight Biologics SA (DE:G49N)
FRANKFURT:G49N
Germany Market

GenSight Biologics SA (G49N) Financial Statements

Compare
1 Followers

GenSight Biologics SA Financial Overview

GenSight Biologics SA's market cap is currently €21.94M. The company's EPS TTM is €-0.05; its P/E ratio is -0.69; GenSight Biologics SA is scheduled to report earnings on September 29, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 2.63M€ 1.27M€ 2.58M€ 5.28M€ 4.39M
Gross Profit€ 2.63M€ 3.00M€ 2.58M€ 5.28M€ 4.39M
Operating Income€ -15.81M€ -29.70M€ -27.84M€ -28.13M€ -24.93M
EBITDA€ -14.76M€ -21.73M€ -26.77M€ -25.52M€ -34.13M
Net Income€ -14.00M€ -26.22M€ -27.62M€ -28.62M€ -34.02M
Balance Sheet
Cash & Short-Term Investments€ 2.46M€ 2.13M€ 10.61M€ 44.29M€ 37.94M
Total Assets€ 10.76M€ 9.13M€ 25.94M€ 56.65M€ 47.36M
Total Debt€ 19.11M€ 23.54M€ 12.65M€ 12.57M€ 14.45M
Net Debt€ 16.65M€ 21.40M€ 2.04M€ -31.72M€ -23.49M
Total Liabilities€ 37.68M€ 39.83M€ 41.22M€ 40.66M€ 35.69M
Stockholders' Equity€ -26.92M€ -30.67M€ -15.28M€ 15.99M€ 11.75M
Cash Flow
Free Cash Flow€ -12.94M€ -24.67M€ -34.01M€ -17.17M€ -15.05M
Operating Cash Flow€ -12.94M€ -24.66M€ -33.75M€ -17.14M€ -15.04M
Investing Cash Flow€ 17.00K€ 209.00K€ 172.00K€ -16.00K€ -376.00K
Financing Cash Flow€ 13.54M€ 15.86M€ 95.00K€ 23.74M€ 33.86M
Currency in EUR

GenSight Biologics SA Earnings and Revenue History

GenSight Biologics SA Debt to Assets

GenSight Biologics SA Cash Flow

GenSight Biologics SA Forecast EPS vs Actual EPS